Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oliff

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Virology|August 1, 1984
Heteroduplex analysis of molecular clones of the pathogenic Friend virus complex: Friend murine leukemia virus, Friend mink cell focus-forming virus, and the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virusM A Gonda, J Kaminchick, A Oliff, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Biochemical and biological analyses of farnesyl-protein transferase inhibitorsN E Kohl, K S Koblan, C A Omer, et al.
Medical and Pediatric Oncology|January 1, 1979
Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalitiesA Oliff, U Bode, B B Bercu, et al.
Cancer Research|August 1, 1987
Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complexL Lu, G Hangoc, A Oliff, et al.
Journal of Medical Primatology|January 1, 1981
Hypothalamic-adenohypophyseal function in male rhesus monkeys. A primate modelG P Chrousos, D Poplack, M Kostolich, et al.
Molecular and Cellular Biology|December 1, 1993
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2FM Ivey-Hoyle, R Conroy, H E Huber, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Development of inhibitors of protein farnesylation as potential chemotherapeutic agentsN E Kohl, M W Conner, J B Gibbs, et al.
FEBS Letters|January 30, 1995
An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-gamma 1P S Huang, L Davis, H Huber, et al.
Gene|November 30, 1998
Multiple control elements are required for expression of the human CD34 geneH S Radomska, A B Satterthwaite, T C Burn, et al.
Cancer Research|November 15, 1995
A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell linesL Sepp-Lorenzino, Z Ma, E Rands, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Virology|August 1, 1984
Heteroduplex analysis of molecular clones of the pathogenic Friend virus complex: Friend murine leukemia virus, Friend mink cell focus-forming virus, and the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virusM A Gonda, J Kaminchick, A Oliff, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Biochemical and biological analyses of farnesyl-protein transferase inhibitorsN E Kohl, K S Koblan, C A Omer, et al.
Medical and Pediatric Oncology|January 1, 1979
Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalitiesA Oliff, U Bode, B B Bercu, et al.
Cancer Research|August 1, 1987
Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complexL Lu, G Hangoc, A Oliff, et al.
Journal of Medical Primatology|January 1, 1981
Hypothalamic-adenohypophyseal function in male rhesus monkeys. A primate modelG P Chrousos, D Poplack, M Kostolich, et al.
Molecular and Cellular Biology|December 1, 1993
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2FM Ivey-Hoyle, R Conroy, H E Huber, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Development of inhibitors of protein farnesylation as potential chemotherapeutic agentsN E Kohl, M W Conner, J B Gibbs, et al.
FEBS Letters|January 30, 1995
An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-gamma 1P S Huang, L Davis, H Huber, et al.
Gene|November 30, 1998
Multiple control elements are required for expression of the human CD34 geneH S Radomska, A B Satterthwaite, T C Burn, et al.
Cancer Research|November 15, 1995
A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell linesL Sepp-Lorenzino, Z Ma, E Rands, et al.
Pageof 9